Claim 70% Off TipRanks Premium
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
An update from EZZ Life Science Holdings Ltd. ( (AU:EZZ) ) is now available.
EZZ Life Science Holdings Limited announced the cessation of Glenn Cross as a director effective 28 November 2025. This change in the board may influence the company’s strategic direction and could have implications for its stakeholders, as Cross held significant interests in the company, including 45,000 fully paid ordinary shares and 10,000 performance rights.
The most recent analyst rating on (AU:EZZ) stock is a Hold with a A$1.50 price target. To see the full list of analyst forecasts on EZZ Life Science Holdings Ltd. stock, see the AU:EZZ Stock Forecast page.
More about EZZ Life Science Holdings Ltd.
EZZ Life Science Holdings Limited operates in the life sciences industry, focusing on the development and distribution of health and wellness products. The company is known for its innovative approach to health solutions, catering to a diverse market with a range of products designed to improve quality of life.
Average Trading Volume: 73,532
Technical Sentiment Signal: Sell
Current Market Cap: A$71.47M
For a thorough assessment of EZZ stock, go to TipRanks’ Stock Analysis page.